PD L1 inhibitor SC and IV

World’s First Subcutaneous Immunotherapy for Lung Cancer- Tecentriq® SC, now available in India

Roche Pharma India has launched Tecentriq® (atezolizumab) SC in India, the country’s first subcutaneous (under-the-skin) immunotherapy for lung cancer that…